PRKDC and infection: To further evaluate the effect of these pathways on γ-H2AX expression, we treated RD cells with an ATR inhibitor (VE-821), DNA-PK inhibitor (KU 57788), or ATM inhibitor (KU 55933) at 2 h post infection with EVA71 (MOI = 2).